Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 6, 2009
Company updates third quarter financial results and full-year 2009 guidance
-
Nov 2, 2009
Third-generation drug-eluting stent now available in CE Mark countries
-
Oct 19, 2009
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2009, as well as guidance for...
-
Oct 9, 2009
Company to webcast its conference call on October 20. Learn how to tune in
-
Oct 6, 2009
Three models of stenting system now available for palliative treatment of malignant common bile duct strictures
-
Oct 5, 2009
Study to determine which device programming strategy best minimizes the occurrence of unnecessary therapy in ICD and CRT-D patients
-
Sep 29, 2009
Agreement will settle more than a dozen lawsuits involving intellectual property in the interventional cardiology arena
-
Sep 25, 2009
Largest randomized trial to compare the use of drug-eluting stents to bare-metal stents for AMI patients
-
Sep 23, 2009
Results support benefits of paclitaxel-eluting stents in diabetic patients
-
Sep 22, 2009
Three-year TAXUS ATLAS results show safety and efficacy advantages for Boston Scientific TAXUS Liberte Stent